New cancer clinical trial: Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Published on: December 03, 2018 at 12:00PM
Condition:   Metastatic Castrate Resistant Prostate Cancer
Interventions:   Drug: Masitinib;   Drug: Docetaxel;   Drug: Prednisone;   Drug: Placebo
Sponsor:   AB Science
Recruiting
https://ift.tt/2Qvk6Vj